Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 2, 2013, Pages 291-299

  Du, Zhen Yu ^a,b   Ma, Tao ^c   Liaset, Bjørn ^b   Keenan, Alison H ^c   Araujo, Pedro ^b   Lock, Erik Jan ^b   Demizieux, Laurent ^d   Degrace, Pascal ^d   Frøyland, Livar ^b   Kristiansen, Karsten ^c   Madsen, Lise ^b,c  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b INSTITUTE OF MARINE RESEARCH   (Norway)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Chu   (France)

Author keywords

Carnitine; Eicosapentaenoic acid; Hepatic triglyceride accumulation; Inflammation; Mildronate; Mitochondrial fatty acid oxidation

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINE OXIDASE (FLAVIN CONTAINING); ASPARTATE AMINOTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE I; CYCLOOXYGENASE 2; CYTOCHROME P450 1A1; FATTY ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; ICOSANOID; ICOSAPENTAENOIC ACID; INSULIN; INTERLEUKIN 6; LEPTIN; LEUKOTRIENE B4; LEUKOTRIENE B5; MELDONIUM; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E2; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DIET SUPPLEMENTATION; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LIVER; LIVER MITOCHONDRION; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ANIMALS; DIETARY SUPPLEMENTS; EICOSAPENTAENOIC ACID; FATTY ACIDS; LIVER; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; TRIGLYCERIDES;

MUS;

EID: 84868518248     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.10.002     Document Type: Article

References (35)

1. P. Angulo Nonalcoholic fatty liver disease N. Engl. J. Med. 346 2002 1221 1231
2. M. Choudhury, K.R. Jonscher, and J.E. Friedman Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat Aging (Albany NY) 3 2011 175 178
3. B.B. Lowell, and G.I. Shulman Mitochondrial dysfunction and type 2 diabetes Science 307 2005 384 387
4. N.E. Sunny, E.J. Parks, J.D. Browning, and S.C. Burgess Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease Cell Metab. 14 2011 804 810
5. J. Araya, R. Rodrigo, L.A. Videla, L. Thielemann, M. Orellana, P. Pettinelli, and J. Poniachik Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease Clin. Sci. (Lond.) 106 2004 635 643
6. T. Ma, B. Liaset, Q. Hao, R.K. Petersen, E. Fjære, H.T. Ngo, H.H. Lillefosse, S. Ringholm, S.B. Sonne, J.T. Treebak, H. Pilegaard, L. Frøyland, K. Kristiansen, and L. Madsen Sucrose counteracts the anti-inflammatory effect of fish oil in adipose tissue and increases obesity development in mice PLoS One 6 2011 e21647
7. S. Kajikawa, T. Harada, A. Kawashima, K. Imada, and K. Mizuguchi Highly purified eicosapentaenoic acid prevents the progression of hepatic steatosis by repressing monounsaturated fatty acid synthesis in high-fat/high-sucrose diet-fed mice Prostaglandins Leukot. Essent. Fatty Acids 80 2009 229 238
8. L. Frøyland, L. Madsen, H. Vaagenes, G.K. Totland, J. Auverx, H. Kryvi, B. Staels, and R.K. Berge Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism J. Lipid Res. 38 1997 1851 1858
9. L. Madsen, A.C. Rustan, H. Vaagenes, K. Berge, E. Dyrøy, and R.K. Berge Eicosapentaenoic and docosahexaenoic acid affect mitochondrial and peroxisomal fatty acid oxidation in relation to substrate preference Lipids 34 1999 951 963
10. G.S. Masterton, J.N. Plevris, and P.C. Hayes Review article: omega-3 fatty acids - a promising novel therapy for non-alcoholic fatty liver disease Aliment. Pharmacol. Ther. 31 2010 679 692
11. H. Shapiro, M. Tehilla, J. Attal-Singer, R. Bruck, R. Luzzatti, and P. Singer The therapeutic potential of long-chain omega-3 fatty acids in nonalcoholic fatty liver disease Clin. Nutr. 30 2011 6 19
12. I. Ikeda, K. Wakamatsu, A. Inayoshi, K. Imaizumi, M. Sugano, and K. Yazawa Alpha-linolenic, eicosapentaenoic and docosahexaenoic acids affect lipid metabolism differently in rats J. Nutr. 124 1994 1898 1906
13. N. Willumsen, S. Hexeberg, J. Skorve, M. Lundquist, and R.K. Berge Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats J. Lipid Res. 34 1993 13 22
14. L. Madsen, L. Frøyland, E. Dyrøy, K. Helland, and R.K. Berge Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation J. Lipid Res. 39 1998 583 593
15. Z.Y. Du, P. Araujo, I. Stubhaug, and L. Frøyland Unbound DHA causes a high blank value in β-oxidation assay: a concern for in vitro studies Eur. J. Lipid Sci. Technol. 112 2010 333 342
16. Z.Y. Du, T. Ma, S. Winterthun, K. Kristiansen, L. Frøyland, and L. Madsen beta-oxidation modulates metabolic competition between eicosapentaenoic acid and arachidonic acid regulating prostaglandin E(2) synthesis in rat hepatocytes-Kupffer cells Biochim. Biophys. Acta 1801 2010 526 536
17. H. Osmundsen, H. Braud, F. Beauseigneur, J. Gresti, M. Tsoko, and P. Clouet Effects of dietary treatment of rats with eicosapentaenoic acid or docosahexaenoic acid on hepatic lipid metabolism Biochem. J. 331 1998 153 160
18. P. Degrace, L. Demizieux, Z.Y. Du, J. Gresti, L. Caverot, L. Djaouti, T. Jourdan, B. Moindrot, J.C. Guilland, J.F. Hocquette, and P. Clouet Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats J. Biol. Chem. 282 2007 20816 20826
19. M. Cave, I. Deaciuc, C. Mendez, Z. Song, S. Joshi-Barve, S. Barve, and C. McClain Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition J. Nutr. Biochem. 18 2007 184 195
20. P. Loria, L.E. Adinolfi, S. Bellentani, E. Bugianesi, A. Grieco, S. Fargion, A. Gasbarrini, C. Loguercio, A. Lonardo, G. Marchesini, F. Marra, M. Persico, D. Prati, and G.S. Baroni NAFLD Expert Committee of the Associazione Italiana per lo studio del Fegato. Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee Dig. Liver Dis. 42 2010 272 282
21. 2 in plasma using experimental design and liquid chromatography tandem mass spectrometry J. Chromatogr. B 830 2006 212 217
22. Z.Y. Du, T. Ma, E.J. Lock, Q. Hao, K. Kristiansen, L. Frøyland, and L. Madsen Depot-dependent effects of adipose tissue explants on co-cultured hepatocytes PLoS One 6 2011 e20917
23. L. Demizieux, P. Degrace, J. Gresti, O. Loreau, J.P. Noël, J.M. Chardigny, J.L. Sébédio, and P. Clouet Conjugated linoleic acid isomers in mitochondria: evidence for an alteration of fatty acid oxidation J. Lipid Res. 43 2002 2112 2122
24. H. Weissbach, T.E. Smith, J.W. Daly, B. Witkop, and S. Udenfriend A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine J. Biol. Chem. 235 1960 1160 1163
25. P. Araujo, Y. Zeng, Z.Y. Du, T.T. Nguyen, L. Frøyland, and B. Grung Discrimination of n-3 rich oils by gas chromatography Lipids 45 2010 1147 1158
26. J.H. Tong, M. Limson-Zamora, A. D'Iorio, and N. Bégin-Heick Liver monoamine oxidase in the obese-hyperglycaemic (ob/ob) mouse Biochem. J. 177 1979 943 949
27. A. Nocito, F. Dahm, W. Jochum, J.H. Jang, P. Georgiev, M. Bader, E.L. Renner, and P.A. Clavien Serotonin mediates oxidative stress and mitochondrial toxicity in a murine model of nonalcoholic steatohepatitis Gastroenterology 133 2007 608 618
28. D.Y. Oh, S. Talukdar, E.J. Bae, T. Imamura, H. Morinaga, W. Fan, P. Li, W.J. Lu, S.M. Watkins, and J.M. Olefsky GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects Cell 142 2010 687 698
29. Y. Zhang, L. Dong, X. Yang, H. Shi, and L. Zhang α-Linolenic acid prevents endoplasmic reticulum stress-mediated apoptosis of stearic acid lipotoxicity on primary rat hepatocytes Lipids Health Dis. 10 2011 81
30. M.S. Lee, I.S. Kwun, and Y. Kim Eicosapentaenoic acid increases lipolysis through up-regulation of the lipolytic gene expression and down-regulation of the adipogenic gene expression in 3T3-L1 adipocytes Genes Nutr. 2 2008 327 330
31. L. Madsen, R.K. Petersen, and K. Kristiansen Regulation of adipocyte differentiation and function by polyunsaturated fatty acids Biochim. Biophys. Acta 1740 2005 266 286
32. M.S. Rao, and J.K. Reddy Peroxisomal beta-oxidation and steatohepatitis Semin. Liver Dis. 21 2001 43 55
33. H. Tilg The role of cytokines in non-alcoholic fatty liver disease Dig. Dis. 28 2010 179 185
34. H. Tilg, and A.R. Moschen Insulin resistance, inflammation, and non-alcoholic fatty liver disease Trends Endocrinol. Metab. 19 2008 371 379
35. W. Nseir, A. Shalata, A. Marmor, and N. Assy Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease Dig. Dis. Sci. 56 2011 3439 3449